推荐应用
LILRA6, also known as ILT8 and CD85b, is a transmembrane molecule that belongs to the LILR family of immune regulatory proteins. Among family members, LILRA6 is most closely related to LILRB3/CD85a/ILT5; these proteins share 94% amino acid (aa) sequence identity in their extracellular domains (ECD). Mature human LILRA6 consists of a 424 aa ECD with two immunoglobulin-like domains, a 21 aa transmembrane segment, and a 13 aa cytoplasmic domain. It contains a positively charged arginine residue in the transmembrane segment which may mediate association with the signaling protein Fc epsilon RI gamma. Alternative splicing generates a short isoform that is truncated near the middle of the ECD. LILRA6 is highly polymorphic, and its gene is found in variably copy numbers. LILRA6 is primarily expressed on monocytes.
高纯度、高活性、低内毒素、高批间一致性
产品数据

-25 ~ -15℃保存,收到货之后有效期1年。 复溶后, 无菌条件下,-85 ~ -65℃保存,3个月有效期。
【应用方向】BCMA/TNFRSF17:多发性骨髓瘤免疫治疗的核心靶点蛋白
81
2026-08-31
【应用方向】CD20:B细胞恶性肿瘤免疫治疗的核心靶点蛋白
76
2026-08-31
【应用方向】CD19:血液肿瘤免疫治疗的核心靶点蛋白
84
2026-08-31
【应用方向】免疫检查点核心家族:B7-CD28超家族蛋白
990
2026-04-21
【应用方向】TIM-3:下一代肿瘤免疫检查点治疗的核心靶点
718
2026-04-21
【应用方向】SIRP家族分子详解与产品选择指南
612
2026-04-21
【应用方向】OX40-OX40L共刺激轴的T细胞存活调控
675
2026-04-21
【应用方向】LILRB家族:髓系细胞免疫检查点的研究前沿与产品解决方案
906
2026-04-21
【应用方向】LAG-3(CD223):T细胞耗竭调控网络的核心节点
810
2026-04-21
【应用方向】B7-H3(CD276):双重功能免疫检查点的分子特征与科研应用
1328
2026-04-20





